Difference between revisions of "Kiladjian JJ, et al. Hematol. Am. Soc. Hematol. Educ. Program (2012) cited as Ref 315 in DOI: 10.1038/s41392-020-0110-5 (Q9578)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Published In Name String (P102): Hematol. Am. Soc. Hematol. Educ. Program, #quickstatements; #temporary_batch_1590006349955)
(‎Created claim: Page(s) (P105): 561-566, #quickstatements; #temporary_batch_1590074839150)
 
(2 intermediate revisions by the same user not shown)
Property / Volume
 +
2012
Property / Volume: 2012 / rank
 +
Normal rank
Property / title
 +
The spectrum of JAK2-positive myeloproliferative neoplasms (English)
Property / title: The spectrum of JAK2-positive myeloproliferative neoplasms (English) / rank
 +
Normal rank
Property / Page(s)
 +
561-566
Property / Page(s): 561-566 / rank
 +
Normal rank

Latest revision as of 15:37, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Kiladjian JJ, et al. Hematol. Am. Soc. Hematol. Educ. Program (2012) cited as Ref 315 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Kiladjian JJ
    0 references
    2012
    0 references
    Hematol. Am. Soc. Hematol. Educ. Program
    0 references
    2012
    0 references
    The spectrum of JAK2-positive myeloproliferative neoplasms (English)
    0 references
    561-566
    0 references